Breaking News
September 19, 2018 - Novel deep learning drug discovery platform gets £1 million innovation boost
September 19, 2018 - Sensor array may detect de novo Parkinson’s disease in breath
September 19, 2018 - A roadmap for the future of electronic health records
September 19, 2018 - Surprising research showing peptide adaptability may pave way to develop immunotherapies
September 19, 2018 - Amyloid β protein makes comeback as therapeutic target for Alzheimer’s disease
September 19, 2018 - Alcon expands its global support of eye care professionals through Alcon Experience Academy
September 19, 2018 - Study gives new insights into how cells leverage GPCRs to control inflammation
September 19, 2018 - Automatic relevance detection in ophthalmic surgery videos
September 19, 2018 - UNIST to accelerate discovery, development of new medicines for incurable diseases
September 19, 2018 - Novel clinical trial to examine cannabis as potential treatment for essential tremor
September 19, 2018 - Salsa dancers have lower injury rates than Spanish, aerobic or Zumba dancers
September 19, 2018 - Bristol-Myers Squibb’s Novel, Oral, Selective TYK2 Inhibitor Delivered Significant Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis in Phase 2 Trial
September 19, 2018 - Can work stress contribute to Parkinson’s disease risk?
September 19, 2018 - Global Climate Action Summit: A focus on kids and climate
September 19, 2018 - Vitamin D may reduce breast cancer mortality in women with lower BMI
September 19, 2018 - Targeted Lung Denervation procedure significantly reduces COPD problems
September 19, 2018 - FDA-approved ‘safe’ daily BPA exposure may contribute to insulin resistance
September 19, 2018 - Research finds physical connection between the brain’s fluid reservoirs and meningeal lymphatics
September 19, 2018 - UCalgary study could help physicians make better treatment decisions for stroke
September 19, 2018 - Biomedical review finds failure rates in some surgical mesh treatments to be unacceptably high
September 19, 2018 - Researchers develop more accurate measure of body fat
September 19, 2018 - Doctors and students rally to support gun violence research, education
September 19, 2018 - LEO Pharma and MorphoSys announce expansion of strategic alliance to develop peptide-derived drugs
September 19, 2018 - Seniors in pain hop aboard the canna-bus
September 19, 2018 - New compound could prevent malaria parasites from maturing inside mosquito
September 19, 2018 - Scientists find alterations in blood flow in response to body position change
September 19, 2018 - UNC Health Care extends free access to virtual care service in the aftermath of Hurricane Florence
September 19, 2018 - Opioid Refills Rare After Rhinoplasty
September 19, 2018 - Corn, obesity, and navigating healthy eating choices as a parent
September 19, 2018 - Journal editor aims to prompt thoughtful review of ethics in precision health
September 19, 2018 - Researchers identify key step in how plant cells respond to pathogens
September 18, 2018 - Researchers analyze how exposure to silver nanoparticles affects zebrafish
September 18, 2018 - Study shows air pollution may be bad for the fetus
September 18, 2018 - Coffee May Have Another Perk for Kidney Patients
September 18, 2018 - Tongue-in-cheek Nobels honor nutritional analysis of cannibalism, roller-coaster kidney stones treatment
September 18, 2018 - Progress, priorities, challenges are focus of State of Stanford Medicine | News Center
September 18, 2018 - Established Alzheimer’s Risk Gene Has a New Role
September 18, 2018 - Hospitalization after antibiotic initiation found to be higher for people with Alzheimer’s disease
September 18, 2018 - Many children with special healthcare needs do not have access to ‘PCMH-concordant’ care
September 18, 2018 - Investigational nasal influenza vaccine tested in children and teens
September 18, 2018 - Lymphatic vessels surrounding the brain play crucial role in multiple sclerosis, research suggests
September 18, 2018 - New fiber laser-based ultrasound sensor may have potential applications in medical diagnostics
September 18, 2018 - Protect your heart and health during ‘dog days’ of summer
September 18, 2018 - Faculty receive awards for promise in biomedical research, clinical care | News Center
September 18, 2018 - Digital games for CVD-related self-management improve exercise capacity and energy expenditure
September 18, 2018 - Aluminum inclusions help enhance adsorption of chemo drugs onto active carbon delivery capsule
September 18, 2018 - Adding PET scans to CT imaging can change treatment for women with cervical cancer
September 18, 2018 - UCSF awarded $20 million grant to study impacts of new, emerging tobacco products
September 18, 2018 - Human brains may be wired to prefer lying on the couch, suggests research
September 18, 2018 - Zika virus vaccine shows promise for treatment of fatal glioblastoma
September 18, 2018 - Theravance Biopharma and Mylan to Report New Data from Phase 3 Studies of Yupelri (revefenacin) in Oral Presentation at European Respiratory Society International Congress 2018
September 18, 2018 - INSiGHT identifies unique retinal regulatory genes
September 18, 2018 - Diversity, science leadership grants awarded to student-faculty pairs | News Center
September 18, 2018 - Many parents blame electronics for sleep problems among teens
September 18, 2018 - Researchers study neuronal activity in brain that prevents individuals from doing physical activity
September 18, 2018 - Purifying Proteins from Mammalian Cell Culture
September 18, 2018 - Researchers map 3D structure of toxic proteins used by Pseudomonas aeruginosa to trigger infection
September 18, 2018 - Outcome of ACL reconstruction related to the way you move post-surgery
September 18, 2018 - Study aims to investigate risk factors for PPCs in surgical patients with gastric cancer
September 18, 2018 - Ardelyx Submits New Drug Application for Tenapanor for IBS-C
September 18, 2018 - Sociodemographic disparities in eyeglass use among elderly
September 18, 2018 - New Drug Shows Promise for Progressive Form of MS
September 18, 2018 - Babies exposed to higher levels of organochlorine compounds in womb may have worse lung function
September 18, 2018 - Women exposed to trauma in their lives gave birth to underweight male infants
September 18, 2018 - Probiotic supplementation may reduce use of antibiotics, scientific analysis shows
September 18, 2018 - Resveratrol decreases pain severity and levels of inflammatory biomarkers in osteoarthritis patients
September 18, 2018 - Research shows pollution is reaching the placenta
September 18, 2018 - KAIST researchers develop heart-targeting drug delivery technology using tannin acid
September 18, 2018 - Muscle relaxants used during general anesthesia can increase risk of pulmonary complications
September 18, 2018 - Silicone breast implants may increase risk of rare adverse outcomes in women
September 18, 2018 - Pediatricians Have a Role in Encouraging Play Among Children
September 18, 2018 - California’s Medicaid program hits ‘print’ when the feds need info
September 18, 2018 - Genes, environment and schizophrenia—new study finds the placenta is the missing link
September 18, 2018 - Boehringer Ingelheim announces study results of COPD patients treated with Spiolto Respimat
September 18, 2018 - PAREXEL launches Patient Innovation Center to improve drug development process
September 18, 2018 - Children’s National and NIAID launch pediatric clinical research partnership
September 18, 2018 - Researchers may be overlooking complexities in social relations of primates
September 18, 2018 - Key signaling molecule that helps stem cells make healthy bone declines as we age
September 18, 2018 - More women veterans with chronic pain use CIH therapies than men
September 18, 2018 - As Earth Warms, Heat-Related Deaths Will Multiply
Genes found related to the reduction of proteins that contribute to Alzheimer’s onset

Genes found related to the reduction of proteins that contribute to Alzheimer’s onset

image_pdfDownload PDFimage_print
Diagram of the brain of a person with Alzheimer’s Disease. Credit: Wikipedia/public domain.

In the ongoing quest for a successful treatment for Alzheimer’s disease, a team of scientists from several leading research institutions have created a map of the molecular network in the aging brain. Molecular networks are cellular and subcellular structures in an organism and the structures’ physical interaction between molecules, RNA, or proteins.

The researchers used their map to identify two new Alzheimer’s disease target genes—that is, genes that can be deleted, added, or modified, in the ongoing quest for a successful treatment for the disease. The team presented their findings in a paper published in Nature Neuroscience on May 25.

Led by principal investigators Dr. David A. Bennett at Rush University Medical Center in Chicago and Dr. Philip L. De Jager at Columbia University in New York, the research team is part of the Accelerating Medicines Program for Alzheimer’s disease. Known as the AMP-AD, the program seeks to leverage advances in analytic methods and large-scale molecular profiles of the aging brain to identify novel therapeutic targets for Alzheimer’s disease.

The National Institute on Aging and the Foundation for the National Institutes of Health spearheaded the development of AMP-AD in collaboration with several industry and non-profit partners. The program launched in 2013.

Map distinguishes between events leading to brain pathology and to loss of cognitive function

The network described in the Nature Neuroscience manuscript accounts for all older people, not just those that meet certain diagnostic guidelines. Further, it separates molecular events that lead to changes in brain tissue (pathology) from those involved in loss of cognitive function, which is the true target of therapeutic efforts.

“Prior network approaches had not considered the detailed change in cognitive state over time of older individuals,” said Bennett. “Instead, they had relied on comparisons of cases from a dementia clinic with volunteers who after their deaths came to autopsy without ever developing dementia. This does not capture the variability over time exhibited by a diverse population of older individuals.”

The burden of Alzheimer’s disease on our aging human populations is growing rapidly, but current therapeutic strategies targeting a small number of proteins have yet to yield a successful treatment.

Analysis honed in on genes most likely to drive cognitive decline

The study drew on data about the deeply characterized subjects from two community-based studies based at the Rush Alzheimer Disease Center. Participants in these studies receive extensive medical testing and evaluation while alive and donate their brains to research upon their deaths. None of the participants had a diagnosis of dementia when they enrolled in the study, but some later developed it.

The investigators have created a unique resource that links molecular changes in nearly 500 older brains profiled in this study to both the individual trajectories of participants’ change in cognition over multiple years prior to death and detailed measures of Alzheimer’s disease and other common brain pathologies measured after death. “We have a detailed picture of brain function before death and an extensive evaluation of the molecular features of each individual brain,” De Jager observed.

Co-lead author Chris Gaiteri, Ph.D., also from the Rush Alzheimer’s Disease Center, added that “unlike traditional studies, all possible outcomes and molecular events are considered simultaneously, enabling us to prioritize a few large groups of genes that are most likely to lead directly to cognitive decline and/or brain pathology, instead of having to focus on a large list of individual genes.”

His co-lead author, Sara Mostafavi, Ph.D., of the University of British Columbia, extended this comment, “The strength of our analytic approach is that it makes no assumptions as far as what genes are important,” she said.

“While we find thousands of genes associated with cognitive decline, we do not simply go for the strongest gene. We find patterns that lead to cognitive decline and then prioritize a small subset of genes that appear to be driving these large-scale changes.”

Experiment reduced genes’ production of protein that contributes to Alzheimer’s

These so called “driver genes” are potentially excellent candidates or targets for developing Alzheimer’s disease therapies. However, statistical analyses are not enough.

Therefore co-investigator Tracy Young-Pearse, Ph.D., from Brigham and Women’s Hospital designed an experiment in which some of these target genes were perturbed to see if this change affected known molecules involved in Alzheimer’s disease.

“When they were altered in human astrocytes, a type of brain cell that plays a key role in maintaining brain function, two of the 14 genes predicted to be driver genes by the network displayed a reduction in the secretion of amyloid beta, a protein that contributes to the onset of Alzheimer’s disease,” Young-Pearse said. These two genes make proteins and the approach raises the possibility that finding drugs that affect those proteins could also lower the production of amyloid beta. Dr. Bennett and his colleagues recently measured a number of the proteins in the network to see if they could replicate the predictions from the network map.

Using the network to predict the 14 driver genes itself was a scientific feat akin to finding the proverbial needle in a haystack, given that the brain map includes about 14,000 genes.

“This study is a milestone in the study of Alzheimer’s disease and the aging brain, said De Jager. “We established a molecular network that not only predicts Alzheimer’s disease genes that can be validated experimentally but also can be repurposed to study very different molecular events involved in brain aging, such as stroke, and the fundamental function of the brain itself.”

Sharing science to spur discoveries

All data and network models were made available to share with the scientific community via the AMP-AD Knowledge Portal and the Rush Alzheimer’s Disease Center Resource Sharing Hub before the publication of the manuscript to enable other investigators to make us of the data and underlying observations for their own studies and to allow them to confirm the results of the study independently.

“This study is the culmination of efforts by the NIA, multiple pharmaceutical industry partners, and a tight-knit group of academic investigators to provide a novel, unbiased perspective on Alzheimer’s disease biology,” said Bennett. “Importantly, this approach does not focus on a single gene of interest, but rather searches for the key nodal point in a network where an intervention may be most likely to have an effect on a devastating disease that remains untreated today.”

While the two genes identified as candidates by the network approach and its validation need further study before they can be used as the basis for drug development efforts, this report is an important milestone for AMP-AD Target Discovery program. It shows the potential of the open science research model to deliver new disease insights with high translational potential and to create unique research resources for the community of pharmaceutical industry, small biotech and academic investigators interested in diversifying the therapeutic approaches for AD and other diseases of the aging brain.


Explore further:
Genes associated with resilience against brain pathology identified

More information:
Sara Mostafavi et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease, Nature Neuroscience (2018). DOI: 10.1038/s41593-018-0154-9

Journal reference:
Nature Neuroscience

Provided by:
Rush University Medical Center

Tagged with:

About author

Related Articles